Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunohistochemistry”

119 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 119 results

Not applicableUnknownNCT06007989
What this trial is testing

Assessing the Relationship Between Hypoxia and the Immune Environment in Myeloma Patients (CHIME)

Who this might be right for
Myeloma
The Christie NHS Foundation Trust 10
Large-scale testing (Phase 3)Looking for participantsNCT05950945
What this trial is testing

Trastuzumab Deruxtecan (T-DXd) in Patients Who Have Hormone Receptor-negative and Hormone Receptor-positive HER2-low or HER2 IHC 0 Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Daiichi Sankyo 250
Not applicableLooking for participantsNCT04300101
What this trial is testing

Mixed Molecular Clinical Index (MMCI) in Diffuse Large B-cell Lymphoma (DLBCL)

Who this might be right for
Diffuse Large B Cell Lymphoma
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 300
Not applicableNot Yet RecruitingNCT06827639
What this trial is testing

In-depth Characterization of Circulating and Infiltrating Immune Subsets and Tumor Cells in Cancer Patients

Who this might be right for
Head and Neck CancerUrologic CancerLung Cancer+2 more
Assistance Publique Hopitaux De Marseille 640
Not applicableStudy completedNCT06925113
What this trial is testing

Investigate the Prevalence of Human Epidermal Growth Factor Receptor 2 (HER2) Immunohistochemistry (IHC) 3+ and Characterize the Clinicopathologic Features of Gynecologic Cancers in Taiwan

Who this might be right for
Cervical CancersEndometrial CancerOvarian Cancer
Daiichi Sankyo 509
Not applicableUnknownNCT01028898
What this trial is testing

Abnormal Expression Proteins, Mitochondrial DNA and miRNA of Irritable Bowel Syndrome

Who this might be right for
Irritable Bowel SyndromeDigestive System DiseasesGastrointestinal Diseases+3 more
Chinese PLA General Hospital 180
Testing effectiveness (Phase 2)Study completedNCT01015131
What this trial is testing

18F-FLT-PET in Breast Cancer (MK-0000-139)

Who this might be right for
Breast Cancer
Merck Sharp & Dohme LLC 46
Not applicableLooking for participantsNCT06397066
What this trial is testing

White Light Endoscopy and Magnifying Endoscopy in Assessing the Status of Hp Infection

Who this might be right for
Helicobacter Pylori Infection
Jilin University 168
Very early researchLooking for participantsNCT06366451
What this trial is testing

PBI-MST-01 (NCT04541108) Substudy AZN-05: Intratumoral Microdosing of Rilvegostomig, Volrustomig, Sabestomig, and AZD9592 in HNSCC

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Presage Biosciences 15
Not applicableStudy completedNCT01812902
What this trial is testing

Prospective Study Comparing Extended With Limited Pelvic Lymphadenectomy in Intermediate and High Risk Prostate Cancer Patients Undergoing Radical Prostatectomy

Who this might be right for
Prostate Cancer
University of Sao Paulo 260
Not applicableLooking for participantsNCT04243720
What this trial is testing

Immune Resistance Interrogation Study

Who this might be right for
CancerSolid TumorMetastatic Cancer+1 more
University Health Network, Toronto 100
Not applicableActive Not RecruitingNCT06850506
What this trial is testing

Exploring the Expression Level of Cadherin 6 Protein (CDH6) in Primary Malignant Bone Tumor Specimens and Its Clinical Application in Prognosis Assessment

Who this might be right for
SarcomaSarcoma, BoneEwing Sarcoma+1 more
Peking University People's Hospital 70
Testing effectiveness (Phase 2)Study completedNCT02490696
What this trial is testing

Comparative Study of the Hypoxia Measured in FAZA and F-miso PET/CT Scan in Patients With Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Centre Henri Becquerel 23
Large-scale testing (Phase 3)Study completedNCT01026259
What this trial is testing

Local Warming of Surgical Incisions

Who this might be right for
Surgical Wound Infection
University of Washington 146
Not applicableNot Yet RecruitingNCT06971107
What this trial is testing

Current Microsatellite Stability Results in Colon Cancer

Who this might be right for
Colon AdenocarcinomaMSI Positive Colorectal CancerMSI Negative Colorectal Cancer
Turkish Society of Colon and Rectal Surgery 1,500
Not applicableStudy completedNCT05257057
What this trial is testing

Frequency of Endometrial Cancer Precursors Associated with Lynch Syndrome

Who this might be right for
Lynch SyndromeEndometrial CancerEndometrial Hyperplasia+2 more
WellSpan Health 91
Not applicableNot Yet RecruitingNCT06836765
What this trial is testing

The Relationship Between the Differential Expression of FosB Protein in Laryngeal Cancer Tissues and Clinical Prognosis

Who this might be right for
Laryngeal Carcinoma
Yang ji 100
Very early researchStudy completedNCT06413095
What this trial is testing

PBI-MST-01 (NCT04541108) Substudy MSD-03: Intratumoral Microdosing of Pembrolizumab Alone and With MK-0482 or MK-4830 in HNSCC or STS

Who this might be right for
Head and Neck Squamous Cell CarcinomaSoft Tissue Sarcoma
Presage Biosciences 13
Testing effectiveness (Phase 2)Study completedNCT04031534
What this trial is testing

Study of Hypoxia Measured in F-Miso PET/Scan and MRI in Patients With Squamous Cells Carcinoma

Who this might be right for
Squamous Cell Carcinoma of the Oropharynx
Centre Henri Becquerel 16
Not applicableStudy completedNCT02010047
What this trial is testing

Comparison of qPCR to IHC and FISH for Detection of ALK Fusion Mutations in FFPE Tissue From NSCLC Patients

Who this might be right for
Nonsmall Cell Lung Cancer
British Columbia Cancer Agency 166
Load More Results